Torii Pharmaceutical Co Ltd 2020 AR2
The report highlights Torii Pharmaceutical Co., Ltd.'s business and CSR achievements for the fiscal year ended December 31, 2020. Key milestones included the launch of CORRECTIM® Ointment for atopic dermatitis and ENAROY® Tablets for renal anemia, alongside business structure reforms such as the transfer of the Sakura Plant. In environmental initiatives, the company reduced its greenhouse gas emissions to 1,117 t-CO2, exceeding its target of 1,371 t-CO2. On the social front, Torii reported that women made up 9.9% of management positions and 21.8% of the total workforce.
Company: Torii Pharmaceutical Co Ltd
Sector: Health Care
Country: Japan
Year: 2020
Type: AR2
Pages: 54
Torii Pharmaceutical Co Ltd
Annual Report
The report highlights Torii Pharmaceutical Co., Ltd.'s business and CSR achievements for the fiscal year ended December 31, 2020. Key milestones included the launch of CORRECTIM® Ointment for atopic dermatitis and ENAROY® Tablets for renal anemia, alongside business structure reforms such as the transfer of the Sakura Plant. In environmental initiatives, the company reduced its greenhouse gas emissions to 1,117 t-CO2, exceeding its target of 1,371 t-CO2. On the social front, Torii reported that women made up 9.9% of management positions and 21.8% of the total workforce.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Jan 1, 2020 - Dec 31, 2020
Fiscal Year
2020
Published
May 31, 2021
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Women in Management
Employees